Roman Groisberg

12PUBLICATIONS
94CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Mar 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma.

Galina Lagos, Roman Groisberg, Andrew Elliott

|Dec 03, 2024
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.

Srilatha Simhadri, Jillian N Carrick, Susan Murphy

|Sep 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa

|Apr 18, 2023
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.

Omar Alhalabi, Roman Groisberg, Ralph Zinner

|Jan 13, 2022
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma.

Janice M Mehnert, Tara C Mitchell, Alexander C Huang

Pageof 2

Frequent Collaborators

6 joint publications

Vivek Subbiah

2 joint publications

Jason Roszik

2 joint publications

Ishwaria M Subbiah

2 joint publications

Aung Naing